Answers are grounded in this paper and cite their sources.
At the International Conference on Cancer in London, 1928, Hocking 2 advocated the treatment of malignant new growths by intravenous injections of colloidal uranium. Since it was impossible to prepare a stable colloidal uranium, Hocking deemed it desirable to employ a mixed uranium-thorium colloid which proved stable over a long period of time. The preparation in its final state contained one per cent uranium, was stable for a period of 3 months, and withstood sterilization by boiling. Since no deleterious effects followed the intravenous administration of the colloid and since some apparent benefit resulted from its use, we thought it desirable to treat a small series of advanced cases after the manner suggested by Hocking. The effort was made to select cases in whom little or no beneficial results were to be anticipated through the employment of surgery or radiation and where any untoward results of the intravenous uraniumthorium colloid could not make the patient9s condition appreciably worse. In the course of a few months 8 cases received this treatment. Some of them were given the amount of the colloid recommended by Hocking, others received double that amount, and 2 patients got slightly less than the recommended dosage. The following case reports indicate briefly the course of the disease in a series of patients treated with uranium-thorium colloid.
No takes yet. Share an insight, caveat, or question.
Pack et al. (1930) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: